PDS Biotechnology Corp (PDSB)
3.82
+0.09
(+2.41%)
USD |
NASDAQ |
May 03, 16:00
3.825
0.00 (0.00%)
Pre-Market: 20:00
PDS Biotechnology Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2019 | 29.38M |
| September 30, 2019 | 29.11M |
| June 30, 2019 | 29.11M |
| March 31, 2019 | 29.11M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.028M |
| June 30, 2018 | -0.0831M |
| March 31, 2018 | -0.0994M |
| December 31, 2017 | -0.1887M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.508M |
| June 30, 2017 | -0.5971M |
| March 31, 2017 | -0.6987M |
| December 31, 2016 | -0.6867M |
| September 30, 2016 | -0.8451M |
| June 30, 2016 | -1.053M |
| March 31, 2016 | -1.296M |
| December 31, 2015 | -1.305M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
29.11M
Minimum
Jun 2019
29.38M
Maximum
Dec 2019
29.20M
Average
29.11M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
| Syros Pharmaceuticals Inc | 37.34M |
| PAVmed Inc | 0.758M |
| Altimmune Inc | 13.73M |
| Regeneron Pharmaceuticals Inc | -4.636B |
| iBio Inc | 8.285M |